LUC00356I2 - - Google Patents
Info
- Publication number
- LUC00356I2 LUC00356I2 LU00356C LUC00356C LUC00356I2 LU C00356 I2 LUC00356 I2 LU C00356I2 LU 00356 C LU00356 C LU 00356C LU C00356 C LUC00356 C LU C00356C LU C00356 I2 LUC00356 I2 LU C00356I2
- Authority
- LU
- Luxembourg
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CA2014/050828 WO2016029290A1 (fr) | 2014-08-29 | 2014-08-29 | Formulation à libération plurimodale à base de doxylamine et de pyridoxine et/ou de métabolites ou de sels associés |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LUC00356I1 LUC00356I1 (fr) | 2024-08-05 |
| LUC00356I2 true LUC00356I2 (fr) | 2026-05-05 |
Family
ID=55398524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU00356C LUC00356I2 (fr) | 2014-08-29 | 2024-08-05 |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP3185856B1 (fr) |
| JP (1) | JP6272561B2 (fr) |
| KR (1) | KR101831570B1 (fr) |
| CN (1) | CN106794148B (fr) |
| AR (1) | AR101728A1 (fr) |
| AU (1) | AU2014405049B2 (fr) |
| CA (1) | CA2920247C (fr) |
| CY (1) | CY1120788T1 (fr) |
| DK (1) | DK3185856T3 (fr) |
| EA (1) | EA032671B1 (fr) |
| ES (1) | ES2674996T3 (fr) |
| FR (1) | FR24C1000I1 (fr) |
| HU (1) | HUE038969T2 (fr) |
| IL (1) | IL250541B (fr) |
| LU (1) | LUC00356I2 (fr) |
| MX (1) | MX360662B (fr) |
| MY (1) | MY196073A (fr) |
| PH (1) | PH12017500282A1 (fr) |
| PL (1) | PL3185856T3 (fr) |
| PT (1) | PT3185856T (fr) |
| SA (1) | SA517380942B1 (fr) |
| SG (1) | SG11201701448XA (fr) |
| TR (1) | TR201809565T4 (fr) |
| UA (1) | UA118711C2 (fr) |
| WO (1) | WO2016029290A1 (fr) |
| ZA (1) | ZA201701063B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS61368B1 (sr) * | 2018-09-27 | 2021-02-26 | Inibsa Ginecologia S A | Postupak za pripremu višejediničnog oralnog doznog oblika sa modifikovanim oslobađanjem doksilamin sukcinata i piridoksin hidrohlorida |
| AR121619A1 (es) * | 2020-03-25 | 2022-06-22 | Inibsa Ginecologia S A | Una forma de dosificación oral de múltiples unidades de liberación modificada de succinato de doxilamina y clorhidrato de piridoxina y un procedimiento para su preparación |
| AR132739A1 (es) | 2023-05-22 | 2025-07-23 | Italfarmaco Spa | Una forma de dosificación oral de unidades múltiples de succinato de doxilamina y clorhidrato de piridoxina sin dióxido de titanio |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
| CA2350195C (fr) | 2000-12-20 | 2003-06-10 | Duchesnay Inc. | Preparation a delai d'action rapide de chlorhydrate de pyridoxine et de doxylamine succinate |
| TWI292138B (en) * | 2004-03-11 | 2008-01-01 | Mstar Semiconductor Inc | Device for adaptively adjusting video's luminance and related method |
| PL1814527T5 (pl) * | 2004-11-05 | 2021-08-02 | Boehringer Ingelheim International Gmbh | Dwuwarstwowa tabletka zawierająca telmisartan i amlodypinę |
| CN102348452A (zh) * | 2009-03-20 | 2012-02-08 | 诺瓦提斯公司 | 缬沙坦和阿利吉仑的固定剂量组合的盖仑制剂 |
| EP2500016A1 (fr) * | 2011-03-18 | 2012-09-19 | Laboratorios Del. Dr. Esteve, S.A. | Complexe de résinate de doxylamine |
| CA2761212A1 (fr) * | 2011-12-07 | 2013-06-07 | Pharmascience Inc. | Formulation de pyridoxine et de doxylamine a action retardee sans delitant et son procede de fabrication |
| WO2013123569A1 (fr) * | 2012-02-22 | 2013-08-29 | Duchesnay Inc. | Formulation à base de doxylamine et de pyridoxine et/ou de métabolites ou de sels associés |
| JP5914701B2 (ja) * | 2012-02-22 | 2016-05-11 | デュシネイ・インコーポレイテッド | ドキシラミンおよびピリドキシン、ならびに／またはその代謝物もしくは塩の製剤 |
-
2014
- 2014-08-29 SG SG11201701448XA patent/SG11201701448XA/en unknown
- 2014-08-29 KR KR1020177008120A patent/KR101831570B1/ko active Active
- 2014-08-29 HU HUE14900963A patent/HUE038969T2/hu unknown
- 2014-08-29 UA UAA201702935A patent/UA118711C2/uk unknown
- 2014-08-29 CN CN201480081512.3A patent/CN106794148B/zh active Active
- 2014-08-29 CA CA2920247A patent/CA2920247C/fr active Active
- 2014-08-29 EA EA201790477A patent/EA032671B1/ru unknown
- 2014-08-29 MX MX2017002495A patent/MX360662B/es active IP Right Grant
- 2014-08-29 PT PT14900963T patent/PT3185856T/pt unknown
- 2014-08-29 WO PCT/CA2014/050828 patent/WO2016029290A1/fr not_active Ceased
- 2014-08-29 DK DK14900963.1T patent/DK3185856T3/en active
- 2014-08-29 ES ES14900963.1T patent/ES2674996T3/es active Active
- 2014-08-29 PL PL14900963T patent/PL3185856T3/pl unknown
- 2014-08-29 JP JP2017511764A patent/JP6272561B2/ja active Active
- 2014-08-29 TR TR2018/09565T patent/TR201809565T4/tr unknown
- 2014-08-29 AU AU2014405049A patent/AU2014405049B2/en active Active
- 2014-08-29 MY MYPI2017700682A patent/MY196073A/en unknown
- 2014-08-29 EP EP14900963.1A patent/EP3185856B1/fr active Active
-
2015
- 2015-08-31 AR ARP150102789A patent/AR101728A1/es not_active Application Discontinuation
-
2017
- 2017-02-09 IL IL250541A patent/IL250541B/en active IP Right Grant
- 2017-02-13 ZA ZA201701063A patent/ZA201701063B/en unknown
- 2017-02-15 PH PH12017500282A patent/PH12017500282A1/en unknown
- 2017-02-21 SA SA517380942A patent/SA517380942B1/ar unknown
-
2018
- 2018-08-10 CY CY20181100842T patent/CY1120788T1/el unknown
-
2024
- 2024-01-04 FR FR24C1000C patent/FR24C1000I1/fr active Active
- 2024-08-05 LU LU00356C patent/LUC00356I2/fr unknown